Clinical Trial Update: Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed or docetaxel with or without erlotinib for stage IIIB or IV non-small cell lung cancer has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Tarceva (erlotinib)
• Taxotere (docetaxel)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-05